Industries
Showing 1–10 of 21 results
-
Global Surgical Robot Market
The global surgical robot market is poised to grow at a CAGR of around 22.3% over the analysis period of 2021 to 2027, according to StrategyHelix.
-
Global 3D Printed Drugs Market
The global 3D printed drugs market is projected to expand by a CAGR of 2.5% from 2021 through 2027, according to StrategyHelix.
-
Global Molecular Diagnostic Market
The global molecular diagnostic market is poised to grow by US$ 5,945 million during 2021-2027, progressing at a CAGR of 8.9% during the forecast period, according to data and analytics company StrategyHelix.
-
Global Point of Care Testing (POCT) Market
The global point of care testing (POCT) market was around 27 billion USD in 2020, reached 30 billion USD in 2021 (an increase of 9.4% year-on-year), according to StrategyHelix’ analysis.
-
Global In vitro diagnostics (IVD) Market
A statistic by StrategyHelix indicates that the global in vitro diagnostics (IVD) market is set to grow at a healthy compound annual growth rate (CAGR) of 7% in the next five years.
-
Global PD-1 (PD-L1) Therapy Market
According to a statistic by StrategyHelix, the global PD-1 (PD-L1) therapy market is poised to grow at a CAGR of around 16.3% over the analysis period of 2021 to 2027.
-
Global Gastric Cancer Market
At 3% CAGR, the global gastric cancer market, in terms of volume, is projected to reach 1,333 thousand units by 2027, according to data and analytics company StrategyHelix.
-
Global Non-small-cell Lung Carcinoma (NSCLC) Market
According to a statistic by StrategyHelix, the global non-small-cell lung carcinoma (NSCLC) market is poised to grow at a CAGR of around 15.4% over the analysis period of 2021 to 2027.
-
Global Immuno-Oncology Therapy Market
The global immuno-oncology therapy market is expected to increase at a CAGR of 22.6% till 2027, according to data and analytics company StrategyHelix.
-
Global Oncology Drug Market
According to a statistic by StrategyHelix, the global oncology drug market is poised to grow at a CAGR of around 12.6% over the analysis period of 2021 to 2027.